1-2 of 2
Wioletta Makowska
Close
Sort by
Journal Articles

A Multicenter Prospective Study on Efficacy and Safety of Ponatinib in Patients with Chronic Myeloid Leukemia Resistant or Intolerant to Previous Therapy: A 3-Year Report

Tomasz Sacha, MDPhD, Elzbieta Szczepanek, Paulina Dumnicka, PhD, Joanna Gora-Tybor, MD PhD, Joanna Niesiobedzka-Krezel, MDPhD, Witold Prejzner, MD PhD, Ewa Wasilewska, MDPhD, Janusz Kloczko, MDPhD, Hanna Ciepluch, MD, Wioletta Makowska, MD, Elzbieta Patkowska, MD, Joanna Wasilewska, MD, Grazyna Bober, MD, Malgorzata Kopera, MDPhD, Ryszard Wichary, MD, Renata Kroll-Balcerzak, MDPhD, Tomasz Gromek, MDPhD, Malgorzata Wach, MDPhD, Anna Rudkowska-Kazanowska, MD, Magdalena Swiniarska, MD, Edyta Paczkowska, MDPhD, Ewa Medras, MD, Monika Joks, MD, Marta Oller, MD, Renata Kasza, MD, Aleksandra Kostyra, MD, Justyna Gil, MD, Olga Grzybowska-Izydorczyk, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141523
Published: 2020
Journal Articles

Low Serum Albumin Level Predicts the Risk of Azacitidine Early Discontinuation in MDS, CMML and 20-30% AML Patients- Results from the Polaza, the Retrospective Study of the Polish Adult Leukemia Group

Krzysztof Madry, Karol Lis, MD, Andrzej Tukiendorf, Pawel Szwedyk, Katarzyna Kapelko-Słowik, Edyta Subocz, MD PhD, Janusz Halka, MD, Aleksandra Golos, MD PhD, Wioletta Makowska, Anna Masternak, MD, Anna Kopinska, Magdalena Czemerska, Sara Zawadzka-Leska, Patrycja Rusicka, Joanna Drozd-Sokolowska, MD PhD, Wiater Elżbieta, Hołojda Jadwiga, Bartłomiej Pogłódek, Piotr Centkowski, Anna Waszczuk-Gajda, MD PhD, Rafal Machowicz, Grzegorz W Basak, MD PhD Professor, Jadwiga Dwilewicz-Trojaczek
Journal: Blood
Blood (2019) 134 (Supplement_1): 5421.
https://doi.org/10.1182/blood-2019-125632
Published: 2019